ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

Shih-Chao Hsu; Ashok Thorat; Long-Bin Jeng; Ping-Chun Li; Te-Hung Chen; Horng-Ren Yang; Kin-Shing Poon

doi:10.12659/AOT.923502

18 September 2020: Original Paper

ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

Shih-Chao Hsu ^123ABCDEF , Ashok Thorat ^13ABCEF , Long-Bin Jeng ^123ABCDEF* , Ping-Chun Li ^134ADF , Chun-Chieh Yeh ^123BE , Te-Hung Chen ^123BCF , Horng-Ren Yang ^123BDE , Kin-Shing Poon ^35DF

DOI: 10.12659/AOT.923502

Ann Transplant 2020; 25:e923502

Authors information Article notes Copyright and License information

View HTML version

Figure 2 (A, B) Pre-rituximab titers in Era III patient population.

Back to the Article

ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

Your Privacy